Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) is a phase 2, interventional study registered as NCT05913674 by Ciusss de L'Est de l'Île de Montréal, with a registry enrolment figure of 25 participants, started 2026-05-01 and due to reach its primary completion in 2028-05. Interventions recorded: Modified early post-operative intraperitoneal chemotherapy (mEPIC). Conditions listed: Peritoneal Carcinomatosis; Appendiceal Neoplasms; Colorectal Cancer Metastatic. Primary outcome: Feasibility of mEPIC. Colorectal eligibility wording from the registry: "* Histological diagnosis of appendicular or colorectal tumors with peritoneal carcinomatosis, either synchronous (\< 12 months after primary diagnosis) or metachronous (\>12 months after the primary diagnosis)". Sites: Canada. No results are recorded here; the registry entry is the source.